Cargando…

Hepatic glycogen storage diseases are associated to microbial dysbiosis

INTRODUCTION: The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. OBJECTIVES: The primary objective of this study was to investigate associations between GSD and the gut mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Colonetti, Karina, Bento dos Santos, Bruna, Nalin, Tatiéle, Moura de Souza, Carolina Fischinger, Triplett, Eric W., Dobbler, Priscila Thiago, Schwartz, Ida Vanessa Doederlein, Roesch, Luiz Fernando Wurdig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445422/
https://www.ncbi.nlm.nih.gov/pubmed/30939160
http://dx.doi.org/10.1371/journal.pone.0214582
_version_ 1783408190635900928
author Colonetti, Karina
Bento dos Santos, Bruna
Nalin, Tatiéle
Moura de Souza, Carolina Fischinger
Triplett, Eric W.
Dobbler, Priscila Thiago
Schwartz, Ida Vanessa Doederlein
Roesch, Luiz Fernando Wurdig
author_facet Colonetti, Karina
Bento dos Santos, Bruna
Nalin, Tatiéle
Moura de Souza, Carolina Fischinger
Triplett, Eric W.
Dobbler, Priscila Thiago
Schwartz, Ida Vanessa Doederlein
Roesch, Luiz Fernando Wurdig
author_sort Colonetti, Karina
collection PubMed
description INTRODUCTION: The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. OBJECTIVES: The primary objective of this study was to investigate associations between GSD and the gut microbiota. METHODS: Twenty-four GSD patients on treatment with uncooked cornstarch (UCCS), and 16 healthy controls had their faecal microbiota evaluated through 16S rRNA gene sequencing. Patients and controls were ≥3 years of age and not on antibiotics. Faecal pH, calprotectin, mean daily nutrient intake and current medications were recorded and correlated with gut microbiome. RESULTS: Patients’ group presented higher intake of UCCS, higher prevalence of IBD (n = 04/24) and obesity/overweight (n = 18/24) compared to controls (n = 0 and 06/16, respectively). Both groups differed regarding diet (in patients, the calories’ source was mainly the UCSS, and the intake of fat, calcium, sodium, and vitamins was lower than in controls), use of angiotensin-converting enzyme inhibitors (patients = 11, controls = 0; p-value = 0.001) multivitamins (patients = 22, controls = 01; p-value = 0.001), and mean faecal pH (patients = 6.23; controls = 7.41; p = 0.001). The GSD microbiome was characterized by low diversity and distinct microbial structure. The operational taxonomic unit (OTU) abundance was significantly influenced by faecal pH (r = 0.77; p = 6.8e-09), total carbohydrate (r = -0.6; p = 4.8e-05) and sugar (r = 0.057; p = 0.00013) intakes. CONCLUSIONS: GSD patients presented intestinal dysbiosis, showing low faecal microbial diversity in comparison with healthy controls. Those findings might be due to the disease per se, and/or to the different diets, use of UCSS and of medicines, and obesity rate found in patients. Although the main driver of these differences is unknown, this study might help to understand how the nutritional management affects GSD patients.
format Online
Article
Text
id pubmed-6445422
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64454222019-04-17 Hepatic glycogen storage diseases are associated to microbial dysbiosis Colonetti, Karina Bento dos Santos, Bruna Nalin, Tatiéle Moura de Souza, Carolina Fischinger Triplett, Eric W. Dobbler, Priscila Thiago Schwartz, Ida Vanessa Doederlein Roesch, Luiz Fernando Wurdig PLoS One Research Article INTRODUCTION: The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. OBJECTIVES: The primary objective of this study was to investigate associations between GSD and the gut microbiota. METHODS: Twenty-four GSD patients on treatment with uncooked cornstarch (UCCS), and 16 healthy controls had their faecal microbiota evaluated through 16S rRNA gene sequencing. Patients and controls were ≥3 years of age and not on antibiotics. Faecal pH, calprotectin, mean daily nutrient intake and current medications were recorded and correlated with gut microbiome. RESULTS: Patients’ group presented higher intake of UCCS, higher prevalence of IBD (n = 04/24) and obesity/overweight (n = 18/24) compared to controls (n = 0 and 06/16, respectively). Both groups differed regarding diet (in patients, the calories’ source was mainly the UCSS, and the intake of fat, calcium, sodium, and vitamins was lower than in controls), use of angiotensin-converting enzyme inhibitors (patients = 11, controls = 0; p-value = 0.001) multivitamins (patients = 22, controls = 01; p-value = 0.001), and mean faecal pH (patients = 6.23; controls = 7.41; p = 0.001). The GSD microbiome was characterized by low diversity and distinct microbial structure. The operational taxonomic unit (OTU) abundance was significantly influenced by faecal pH (r = 0.77; p = 6.8e-09), total carbohydrate (r = -0.6; p = 4.8e-05) and sugar (r = 0.057; p = 0.00013) intakes. CONCLUSIONS: GSD patients presented intestinal dysbiosis, showing low faecal microbial diversity in comparison with healthy controls. Those findings might be due to the disease per se, and/or to the different diets, use of UCSS and of medicines, and obesity rate found in patients. Although the main driver of these differences is unknown, this study might help to understand how the nutritional management affects GSD patients. Public Library of Science 2019-04-02 /pmc/articles/PMC6445422/ /pubmed/30939160 http://dx.doi.org/10.1371/journal.pone.0214582 Text en © 2019 Colonetti et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Colonetti, Karina
Bento dos Santos, Bruna
Nalin, Tatiéle
Moura de Souza, Carolina Fischinger
Triplett, Eric W.
Dobbler, Priscila Thiago
Schwartz, Ida Vanessa Doederlein
Roesch, Luiz Fernando Wurdig
Hepatic glycogen storage diseases are associated to microbial dysbiosis
title Hepatic glycogen storage diseases are associated to microbial dysbiosis
title_full Hepatic glycogen storage diseases are associated to microbial dysbiosis
title_fullStr Hepatic glycogen storage diseases are associated to microbial dysbiosis
title_full_unstemmed Hepatic glycogen storage diseases are associated to microbial dysbiosis
title_short Hepatic glycogen storage diseases are associated to microbial dysbiosis
title_sort hepatic glycogen storage diseases are associated to microbial dysbiosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445422/
https://www.ncbi.nlm.nih.gov/pubmed/30939160
http://dx.doi.org/10.1371/journal.pone.0214582
work_keys_str_mv AT colonettikarina hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT bentodossantosbruna hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT nalintatiele hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT mouradesouzacarolinafischinger hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT triplettericw hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT dobblerpriscilathiago hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT schwartzidavanessadoederlein hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis
AT roeschluizfernandowurdig hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis